Categories
FDA Approves Dyad for Public Consumption on July 17 in North America
Today, Dyad was approved by the U.S. Fun and Diversion Administration to administer extreme doses of sensory stimulation. It is absorbed directly into gamers’ cerebral cortex via their optical, audial and touch receptors. The game was approved for use in all patients in North America who are in possession of a PS3 console and $14.99, and who are not adversely affected by excessive synaptic activity. Research on Dyad began in 2008 in TRNT by Shawn McGrath. After TRNT officials observed test subjects wholly absorbed in euphoric trances and reviewed testimonies of transcendental interactive experiences, TRNT halted development of Dyad and expelled Shawn.
